Biobank data, licensed for discovery — not locked in a silo.
Network Bio turns consented biobank collections into research-grade, delivery-ready datasets that biopharma and academic teams can license — cutting cohort sourcing from months to weeks.
Cohort sourcing is where drug programs stall.
Months of IRB negotiation before a single sample arrives
Research teams spend weeks navigating institutional access agreements and re-consent protocols — before any data is even reviewed. By the time samples arrive, program timelines have shifted.
Data delivered in incompatible formats requiring 6 weeks of cleaning
Raw biorepository exports arrive in inconsistent schemas, with undocumented field encodings and mixed-format phenotype tables. Normalization alone costs weeks of engineering time.
Consent records that can't survive legal review at data room stage
Incomplete or ambiguous consent documentation derails licensing transactions at the final review stage. Without an auditable consent chain, deals collapse under regulatory scrutiny.
| Request ID | Therapeutic Area | Stage | Days | Status |
|---|---|---|---|---|
| REQ-0041 | Oncology | IRB Negotiation | 73d | BLOCKED |
| REQ-0038 | Cardiology | Format Cleaning | 41d | PENDING |
| REQ-0035 | Neurology | Consent Review | 58d | BLOCKED |
| REQ-0031 | Oncology | Delivery | 12d | READY |
| REQ-0028 | Metabolic | QC & Enrichment | 29d | PENDING |
| REQ-0024 | Neurology | Licensed | 18d | READY |
From biobank to licensed dataset — with the chain of custody intact.
Index, de-identify & QC
We partner with biobanks to comprehensively index collections, apply Safe Harbor de-identification across all 18 identifiers, and run automated QC checks on every sample record before ingestion.
Append phenotypes & longitudinal data
Clinical phenotypes, genomic variant calls, proteomic profiles, and longitudinal follow-up records are appended and standardized to common schema formats — FHIR R4, VCF, Parquet.
Deliver with full provenance
Every licensed delivery includes a documented dataset package: provenance metadata, consent audit trail, de-identification report, and format documentation — everything your legal team needs for data room review.
Explore available datasets by therapeutic area.
Oncology Cohort Collection
Cardiometabolic Biomarker Panel
Neurological Phenotype Registry
Two distinct buyer journeys — one infrastructure.
Biopharma Teams
Speed and compliance are non-negotiable for programs on a development timeline. Network Bio delivers documented datasets on a defined schedule — with the de-identification and provenance records your legal team requires.
- Defined delivery timelines
- Safe Harbor de-identification package
- FHIR R4 / VCF / Parquet format compatibility
- Dedicated data liaison for every engagement
Academic Research Groups
Academic programs need cost-effective access to well-consented cohort data, with the documentation infrastructure to support IRB review. We provide tiered access options and consent chain documentation aligned to institutional review requirements.
- Cost-effective academic access tiers
- Consent documentation for IRB submission
- Open-science data licensing alignment
- Collaborative cohort design support
Every dataset: de-identified, provenance-documented, consent-verified.
Network Bio datasets are built with HIPAA de-identification standards in mind, applying the Safe Harbor method across all 18 identifiers. Every delivery includes a longitudinal QC report, consent chain documentation, and full provenance metadata — so your team never enters a data room unprepared.
From the teams that sourced data through us.
We had a program waiting on cohort data for four months before working with Network Bio. Getting a pre-indexed, de-identified dataset delivered in our format within a few weeks changed the trajectory of that program entirely.
For our IRB submission, we needed consent chain documentation that would hold up to institutional scrutiny. The provenance package Network Bio included made that process straightforward. Our team actually commented on how clean the documentation was.
Start sourcing your cohort today.
Tell us your therapeutic area, modality, and timeline — we'll match you with available datasets and a path to delivery.